CoChat
Sign Up
Cited by 235Gastrointestinal Bleeding Diagnosis and TreatmentInflammatory mediators and NSAID effectsHelicobacter pylori-related gastroenterology studies

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis

Anglin, Rebecca, Yuan, Yuhong, Moayyedi, Paul, Tse, Frances, Armstrong, David, Leontiadis, Grigorios I·2014·American Journal of Gastroenterology
DOI 10.1038/ajg.2014.82
Open this paper in CoChat — free account

Abstract

Objectives There is emerging concern that selective serotonin reuptake inhibitors (SSRIs) may be associated with an increased risk of upper gastrointestinal (GI) bleeding, and that this risk may be further increased by concurrent use of nonsteroidal anti-inflammatory (NSAID) medications. Previous reviews of a relatively small number of studies have reported a substantial risk of upper GI bleeding with SSRIs; however, more recent studies have produced variable results. The objective of this study was to obtain a more precise estimate of the risk of upper GI bleeding with SSRIs, with or without concurrent NSAID use. Methods MEDLINE, EMBASE, PsycINFO, the Cochrane central register of controlled trials (through April 2013), and US and European conference proceedings were searched. Controlled trials, cohort, case-control, and cross-sectional studies that reported the incidence of upper GI bleeding in adults on SSRIs with or without concurrent NSAID use, compared with placebo or no treatment were included. Data were extracted independently by two authors. Dichotomous data were pooled to obtain odds ratio (OR) of the risk of upper GI bleeding with SSRIs +/- NSAID, with a 95% confidence interval (CI). The main outcome and measure of the study was the risk of upper GI bleeding with SSRIs compared with placebo or no treatment. Results Fifteen case-control studies (including 393,268 participants) and four cohort studies were included in the analysis. There was an increased risk of upper…

Overview

Integrity signals

Registry

Crossref · 10.1038/ajg.2014.82

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Cited by

Sorted by citations

See all 235

Related

Metadata

Authors
Anglin, R., Yuan, Y., Moayyedi, P., Tse, F., Armstrong, D., & Leontiadis, G. I.
Affiliations
McMaster University (CA)
Corresponding author
Anglin, Rebecca
ORCID
Venue
American Journal of Gastroenterology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2014-06
Volume
109
Issue
6
Pages
811-819
ISSN
0002-9270 (ISSN-L)
DOI
10.1038/ajg.2014.82
OpenAlex
W1970727094
Cited by
234
References
44
Citations by year
2026: 18 · 2025: 17 · 2024: 14 · 2023: 12 · 2022: 21 · 2021: 16 · 2020: 14 · 2019: 22 · 2018: 24 · 2017: 35 · 2016: 19 · 2015: 17 · 2014: 4
FWCI
4.10
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (unspecified)
Locations
  • The American Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
Keywords
upper gastrointestinal bleeding, selective serotonin reuptake inhibitors, nonsteroidal anti-inflammatory drugs, drug-drug interactions, adverse drug reactions, antidepressant safety, number needed to harm, risk estimation, combination therapy, prescribing precautions, depression treatment, antidepressant side effects, NSAID adverse effects, antidepressant discontinuation
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Drug Therapy, Combination, Gastrointestinal Hemorrhage, Humans, Risk Factors, Incidence, Selective Serotonin Reuptake Inhibitors, Risk Assessment, Upper Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review